IPR Fundamental Analysis - IMPRESA SGPS SA

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to IPR. IPR was compared to 70 industry peers in the Media industry. IPR may be in some trouble as it scores bad on both profitability and health. IPR is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

IPR had negative earnings in the past year.

IPR had a positive operating cash flow in the past year.

In multiple years IPR reported negative net income over the last 5 years.

Each year in the past 5 years IPR had a positive operating cash flow.

1.2 Ratios

IPR has a worse Return On Assets (-20.73%) than 81.16% of its industry peers.

IPR's Return On Equity of -79.68% is on the low side compared to the rest of the industry. IPR is outperformed by 82.61% of its industry peers.

		Industry Rank	Sector Rank
ROA	-20.73%
ROE	-79.68%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IPR's Gross Margin of 33.46% is on the low side compared to the rest of the industry. IPR is outperformed by 69.57% of its industry peers.

IPR's Gross Margin has declined in the last couple of years.

IPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	33.46%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.81%

GM growth 5Y-10.84%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IPR does not have a ROIC to compare to the WACC, probably because it is not profitable.

IPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -0.35, we must say that IPR is in the distress zone and has some risk of bankruptcy.

IPR has a worse Altman-Z score (-0.35) than 84.06% of its industry peers.

The Debt to FCF ratio of IPR is 15.65, which is on the high side as it means it would take IPR, 15.65 years of fcf income to pay off all of its debts.

IPR's Debt to FCF ratio of 15.65 is on the low side compared to the rest of the industry. IPR is outperformed by 60.87% of its industry peers.

A Debt/Equity ratio of 1.15 is on the high side and indicates that IPR has dependencies on debt financing.

IPR has a Debt to Equity ratio of 1.15. This is in the lower half of the industry: IPR underperforms 60.87% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.15
Debt/FCF	15.65
Altman-Z	-0.35

ROIC/WACCN/A

WACC7.77%

2.3 Liquidity

A Current Ratio of 0.44 indicates that IPR may have some problems paying its short term obligations.

The Current ratio of IPR (0.44) is worse than 85.51% of its industry peers.

IPR has a Quick Ratio of 0.44. This is a bad value and indicates that IPR is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.44, IPR is doing worse than 85.51% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.44
Quick Ratio	0.44

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for IPR have decreased strongly by -3451.33% in the last year.

Looking at the last year, IPR shows a decrease in Revenue. The Revenue has decreased by -3.29% in the last year.

Measured over the past years, IPR shows a decrease in Revenue. The Revenue has been decreasing by -0.34% on average per year.

EPS 1Y (TTM)-3451.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-26.89%

Revenue 1Y (TTM)-3.29%

Revenue growth 3Y-2.2%

Revenue growth 5Y-0.34%

Sales Q2Q%-1.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, IPR is valued cheaply inside the industry as 92.75% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	2.95
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

IPR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

IMPRESA SGPS SA

ELI:IPR (12/17/2025, 7:00:00 PM)

0.171

-0.02 (-10.24%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)07-24 2025-07-24

Earnings (Next)03-11 2026-03-11

Inst Owners0.21%

Inst Owner ChangeN/A

Ins Owners1.51%

Ins Owner ChangeN/A

Market Cap28.73M

Revenue(TTM)176.02M

Net Income(TTM)-67.42M

Analysts84

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.16
P/FCF	2.95
P/OCF	2.41
P/B	0.34
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.4

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.06

FCFY33.89%

OCF(TTM)0.07

OCFY41.53%

SpS1.05

BVpS0.5

TBVpS-0.74

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-20.73%
ROE	-79.68%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	33.46%
FCFM	5.53%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.81%

GM growth 5Y-10.84%

F-Score4

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	1.15
Debt/FCF	15.65
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	1.25%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.44
Quick Ratio	0.44
Altman-Z	-0.35

F-Score4

WACC7.77%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)1.24%

Cap/Sales(5y)1.39%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-3451.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-26.89%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-3.29%

Revenue growth 3Y-2.2%

Revenue growth 5Y-0.34%

Sales Q2Q%-1.12%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-534.9%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y55.43%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y40.06%

OCF growth 3Y-57.59%

OCF growth 5Y-39.33%

IMPRESA SGPS SA / IPR.LS FAQ

What is the fundamental rating for IPR stock?

ChartMill assigns a fundamental rating of 1 / 10 to IPR.LS.

Can you provide the valuation status for IMPRESA SGPS SA?

ChartMill assigns a valuation rating of 2 / 10 to IMPRESA SGPS SA (IPR.LS). This can be considered as Overvalued.

How profitable is IMPRESA SGPS SA (IPR.LS) stock?

IMPRESA SGPS SA (IPR.LS) has a profitability rating of 1 / 10.

IMPRESA SGPS SA (IPR.LS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

IMPRESA SGPS SA / IPR.LS FAQ

What is the fundamental rating for IPR stock?

Can you provide the valuation status for IMPRESA SGPS SA?

How profitable is IMPRESA SGPS SA (IPR.LS) stock?